Paradigm Biocapital Advisors’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $90.6M | Buy |
|
|||||
|
2024
Q1 | $76.8M | Buy |
|
|||||
|
2023
Q4 | $44.3M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $37.6M | Sell |
|
|||||
|
2022
Q4 | $43.1M | Sell |
|
|||||
|
2022
Q3 | $51.4M | Buy |
|
|||||
|
2022
Q2 | $40.2M | Buy |
|
|||||
|
2022
Q1 | $37.7M | Buy |
|
|||||
|
2021
Q4 | $29.3M | Buy |
|